Skip to main
ISRG
ISRG logo

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 29%
Buy 50%
Hold 14%
Sell 0%
Strong Sell 7%

Bulls say

Intuitive Surgical's financial outlook is bolstered by a 14% growth in Ion utilization and a notable increase in its installed base, reaching 954 systems, while the US Da Vinci system utilization observes a 2% rise with enhanced procedural growth. Additionally, the company has achieved a significant 35% increase in SP system utilization, with an installed base now at 345 units, indicating solid demand and adoption in the market. Improved gross margin guidance, rising from 66-67% to 67-67.5%, further reflects strong performance driven by higher US system placements and favorable tariff outlooks, supporting a positive trajectory for the company's financial health.

Bears say

Intuitive Surgical's revenue growth has shown signs of slowing, with Service revenue slightly missing expectations at $396 million, indicating challenges in revenue generation amid macroeconomic uncertainty. The company faces multiple headwinds, including deferred robotic purchasing decisions due to constrained hospital capital budgets, market resistance to robotic surgical approaches in newer markets, and a prolonged rollout of next-generation systems. Additionally, external factors such as tariffs on imports from Mexico and downward pressure on the average selling price and utilization rates due to third-party instrument reprocessing further complicate Intuitive Surgical's financial outlook, suggesting potential challenges ahead for sustained growth.

Intuitive Surgical (ISRG) has been analyzed by 14 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 50% recommend Buy, 14% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 14 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $591.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $591.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.